Desipramine hydrochloride |
58-28-6 |
Norpramin |
Desipramine Hcl |
Pertofrane |
Pertofran |
DMI hydrochloride |
Norpolake |
Nortimil |
Desmethylimipramine chloride |
Desipramine monohydrochloride |
Demethylimipramine hydrochloride |
Imipraminedemethyl hydrochloride |
Desmethylimipramine hydrochloride |
NSC-114901 |
RMI 9,384A |
Desmethylimipramine monohydrochloride |
EX 4355 |
G-35020 |
Desimipramine, hydrochloride |
UNII-1Y58DO4MY1 |
JB 8181 |
JB-8181 |
G 35020 |
58-28-6 (HCl) |
MLS000028418 |
1Y58DO4MY1 |
CHEBI:4449 |
N-(gamma-Methylaminopropyl)iminodibenzyl hydrochloride |
MFCD00058108 |
EX-4355 |
GMI |
Pertofrin |
Petylyl |
SMR000036827 |
10,11-Dihydro-5-(3-(methylamino)propyl)-5H-dibenz(b,f)azepine hydrochloride |
10,11-Dihydro-5-(3-(methylamino)propyl)-5H-dibenz(b,f)azepine monohydrochloride |
3-(5,6-dihydrobenzob1benzazepin-11-yl)-N-methylpropan-1-amine;hydrochloride |
DSSTox_CID_26942 |
DSSTox_RID_82024 |
DSSTox_GSID_46942 |
3-(10,11-dihydro-5H-dibenzob,fazepin-5-yl)-N-methylpropan-1-amine hydrochloride |
3-(10,11-dihydro-5H-dibenzob,fazepin-5-yl)propylmethylamine hydrochloride |
CAS-58-28-6 |
SR-01000003060 |
NCGC00015340-02 |
EINECS 200-373-1 |
NSC 114901 |
iren |
Pertrofan |
Norpramin (TN) |
Prestwick_706 |
Desipramin hydrochloride |
CPD000036827 |
Desipramine hydrochloride USAN:USP:JAN |
Opera_ID_943 |
Desimipramine hydrochloride |
Epitope ID:224551 |
10,fazepine hydrochloride |
5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(methylamino)propyl)-, hydrochloride |
5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N-methyl-, monohydrochloride |
CHEMBL1696 |
SCHEMBL41992 |
MLS000038088 |
MLS001056757 |
MLS002222246 |
MLS002548871 |
SPECTRUM1500227 |
REGID_for_CID_65327 |
10,fazepine monohydrochloride |
Desmethylimipramine-hydrochloride |
DTXSID9046942 |
RMI-9384A |
HMS1569E07 |
HMS1920C22 |
Pharmakon1600-01500227 |
BCP29731 |
EX-A3768 |
HY-B1272 |
Tox21_110129 |
Tox21_500358 |
CCG-38909 |
Desipramine hydrochloride (JAN/USP) |
NSC114901 |
NSC756719 |
s5485 |
AKOS015994722 |
Tox21_110129_1 |
CS-8201 |
KS-1296 |
LP00358 |
NC00681 |
NSC-756719 |
VA10690 |
5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(methylamino)propyl)-, monohydrochloride |
5H-Dibenzb,fazepine-5-propanamine, 10,11-dihydro-N-methyl-,monohydrochloride |
NCGC00015340-14 |
NCGC00093794-01 |
NCGC00093794-02 |
NCGC00093794-03 |
NCGC00093794-04 |
NCGC00093794-05 |
NCGC00261043-01 |
AC-33180 |
DB-053177 |
WLN: T C676 BN&T&J B3M1 &GH |
B7261 |
EU-0100358 |
FT-0603109 |
FT-0666023 |
D 3900 |
D00812 |
5-(4-ISOPROPOXYPHENYL)-5-OXOPENTANOICACID |
Desipramine hydrochloride, >=98% (TLC), powder |
SR-01000003060-2 |
SR-01000003060-8 |
Q27106387 |
N-(.gamma.-Methylaminopropyl)iminodibenzyl hydrochloride |
5H-Dibenzb, 10,11-dihydro-N-methyl-, monohydrochloride |
5-(3-Methylaminopropyl)-5H-dibenzb,fazepine hydrochloride |
Desipramine Hydrochloride 1.0 mg/ml in Methanol (as free base) |
5H-Dibenzb, 10,11-dihydro-5-3-(methylamino)propyl-, hydrochloride |
5H-Dibenzb, 10,11-dihydro-5-3-(methylamino)propyl-, monohydrochloride |
Desipramine hydrochloride solution, drug standard, 1.0 mg/mL in methanol |
Desipramine hydrochloride, European Pharmacopoeia (EP) Reference Standard |
10,11-Dihydro-5-(3-(methylamino)prop-yl)-5h-dibenz(b,f)azepine hydro-chloride |
10-11-Dihydro-N-methyl-5H-dibenz(Z)b,fazepine-5-propanamine hydrochloride |
5H-DIBENZB,FAZEPINE-5-PROPANAMINE, 10,11-DIHYDRO-N-METHYL-,MONOHCL |
Desipramine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material |
Desipramine hydrochloride, United States Pharmacopeia (USP) Reference Standard |
Desipramine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material |
|